YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Bristol-Myers to buy MyoKardia for $13B

Posted online

Bristol-Myers Squibb agreed to purchase MyoKardia for roughly $13 billion.

The deal would give Bristol-Meyers access to experimental heart disease therapy mavacamten.

The purchase agreement follows Bristol-Myers' $74 billion acquisition of Celgene last year.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Open for Business: Belamour

Springfield event venue Belamour LLC gained new ownership; The Wok on West Bypass opened; and Hawk Barber & Shop closed on a business purchase that expanded its footprint to Ozark.

Most Read
SBJ.net Poll
Update cookies preferences